Fotini Lambrianou

  • Citations Per Year
Learn More
BACKGROUND Sulfasalazine is a combination of sulfapyridine and 5-aminosalicylic acid and is used as a first-line treatment in inflammatory bowel disease. OBJECTIVE We describe a case of acute interstitial nephritis that presented after 7 months of sulfasalazine therapy. Despite the discontinuation of the drug, the patient's renal function continued to(More)
  • 1